Marinus Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Aug '25 Aug 11, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Market Capitalization	9,105	9,771	6,577	1,345	282	194	Upgrade
Market Cap Growth	48.57%	48.57%	389.11%	377.02%	45.44%	164.83%	Upgrade
Enterprise Value	9,192	10,379	7,066	1,363	310	232	Upgrade
Last Close Price	45.25	48.56	66.42	38.40	8.05	5.54	Upgrade
PE Ratio	17.81	25.91	7.02	6.49	0.49	11.42	Upgrade
PS Ratio	2.14	2.30	1.25	1.17	0.57	4.10	Upgrade
PB Ratio	1.45	1.55	1.58	0.57	0.19	0.31	Upgrade
P/TBV Ratio	1.45	1.55	1.59	0.57	0.19	0.31	Upgrade
EV/Sales Ratio	2.16	2.44	1.35	1.18	0.63	4.90	Upgrade
EV/EBITDA Ratio	53.89	60.84	13.13	39.01	-	7.44	Upgrade
EV/EBIT Ratio	66.93	75.57	13.74	95.49	-	7.57	Upgrade
EV/FCF Ratio	-3.25	-	-	-	-	-	Upgrade
Debt / Equity Ratio	0.13	0.13	0.14	0.14	0.03	0.07	Upgrade
Debt / EBITDA Ratio	4.70	4.70	1.07	9.66	-	1.36	Upgrade
Asset Turnover	0.68	0.68	1.32	0.49	0.40	0.06	Upgrade
Inventory Turnover	16.74	16.74	30.35	12.78	-	-	Upgrade
Quick Ratio	2.49	2.49	2.10	1.40	3.56	1.77	Upgrade
Current Ratio	5.29	5.29	4.37	2.74	6.29	7.62	Upgrade
Return on Equity (ROE)	7.22%	7.22%	28.72%	10.77%	713.25%	2.75%	Upgrade
Return on Assets (ROA)	1.37%	1.37%	8.09%	0.38%	-19.62%	2.57%	Upgrade
Return on Capital (ROIC)	1.45%	1.45%	8.64%	0.42%	-22.00%	2.90%	Upgrade
Return on Capital Employed (ROCE)	2.10%	2.10%	12.00%	0.60%	-	4.80%	Upgrade
Earnings Yield	4.14%	3.86%	14.24%	15.41%	203.32%	8.76%	Upgrade
FCF Yield	-31.03%	-28.92%	-17.85%	-17.74%	-225.84%	-59.19%	Upgrade
Buyback Yield / Dilution	-61.87%	-61.87%	-161.65%	-	-	-	Upgrade

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.